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-Glucuronidase  inhibitors  are  suggested  as  potential  hepatoprotective  agents.  Swertia  chirayita  (Roxb.)
Buch.-Ham.  ex C.B.  Clarke,  Gentianaceae,  is  known  for  its hepatoprotective  and  anti-hepatotoxic  activ-
ity in  Ayurvedic  system  of  medicine  for  ages.  This  plant  is substituted  by  other  species  like  S.  decussata
Nimmo  ex  C.B.  Clarke  and  S. bimaculata  (Siebold  &  Zucc.)  Hook.  f. &  Thomson  ex  C.B.  Clarke.  The  aim  of  the
study  was to compare  metabolite  proﬁle  and  -glucuronidase  inhibitory  activity  of  these  three  important
species  of  Swertia  and  to identify  the  active  constituents.  S. chirayita  (IC50 210.97  g/ml)  and  S.  decussata
(IC50 269.7  g/ml)  showed  -glucuronidase  inhibitory  activity  signiﬁcantly  higher  than  that  of  silymarin,
the  known  inhibitor  of  the  enzyme.  The  activity  of  S.  bimaculata  was  low.  The  metabolites  present  in the
three species  were  analyzed  by HPLC  and  GC-MS  based  metabolomics  approach.  Five  amino  acids,  twenty
one organic  acids,  one  inorganic  acid,  eight  fatty  acids,  twenty  one  phenols  including  xanthones,  eight
sugars,  seven  sugar  alcohols,  ﬁve  terpenoids  and  amarogentin  were  identiﬁed.  Activities  of  the  xan-
thones  mangiferin  (IC50 16.06  g/ml),  swerchirin  (IC50 162.84  g/ml),  decussatin  (IC50 195.11 g/ml),
1-hydroxy-3,5,8-trimethoxy  xanthone  (IC50 245.97  g/ml),  bellidifolin  (IC50 390.26  g/ml)  were  signiﬁ-
cantly  higher  than that of  silymarin  (IC50 794.62  g/ml).  Quinic  acid (IC50 2.91  mg/ml),  O-acetylsalicylic
acid (IC50 48.4  mg/ml),  citric  acid  (IC50 1.77  mg/ml),  d-malic  acid (IC50 14.82  mg/ml)  and  succinic  acid
(IC50 38.86  mg/ml)  also  inhibited  the  enzyme  -glucuronidase.  The  ﬁndings  suggest  that  constituents,
in addition  to the  xanthones,  probably  also contribute  to  the  bioactivity  of  different  Swertia  species  by
synergistic  effect.  Further  in  vivo study  is required  to support  the  claim.
© 2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
Liver disease has become a major health issue globally (Byass,
014). The liver is a vital organ that is involved in mainte-
ance of metabolic functions and helps in the detoxiﬁcation
rocess by countering several exogenous and endogenous chal-
enges (Kshirsagar et al., 2011). Glucuronidation is a major pathway
f phase II xenobiotic biotransformation (de Graaf et al., 2002).
onjugation of toxins with glucuronic acid deactivates potentially
amaging compounds and subsequently eliminates them from the
ody. However, this process becomes limited by the rate of deglu-
uronidation by -glucuronidase. Hydrolysis of the glucuronide
oiety can be carried out by -glucuronidase present in most of
he tissues, in endocrine and reproductive organs (Dutton, 1980).
∗ Corresponding author.
E-mail: bdbot@caluniv.ac.in (B. De).
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102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Liver damage causes an increase in the level of -glucuronidase in
blood (Pineda et al., 1959), and liver cancer could be related to this
enzyme (Mills and Smith, 1951).
-Glucuronidase inhibitors reduce the carcinogenic potential of
toxic compounds normally excreted in bile after glucuronidation
(Walaszek et al., 1984). Due to this correlation, -glucuronidase
inhibitors are suggested as potential hepatoprotective agents (Shim
et al., 2000). Certain hepatoprotective plant extracts and their
constituents are known to inhibit the enzyme, -glucuronidase
(Joshi and Sanmugapriya, 2007). Silymarin (a mixture of ﬂavono-
lignans), the commercial plant derived -glucuronidase inhibitor
(Kim et al., 1994), is used to treat liver disorders and also certain
cancers (Dixit et al., 2007). But it has poor bioavailability (Dixit et al.,
2007). Silymarin has certain other limitations related to gastroin-
testinal tract like bloating, dyspepsia, nausea, irregular stool and
diarrhoea. It also produced pruritus, headache, exanthema, malaise,
asthenia, and vertigo (Pradhan and Girish, 2006). Hence, search for
glucuronidase inhibitory compounds from medicinally important
traditional plants that are earlier reported to be hepatoprotective
is necessary.
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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Plants of the genus Swertia, Gentianaceae, are well recognized in
iterature as important medicinal herb having an array of biologi-
al and therapeutic properties (Negi et al., 2011). Hepatoprotective
nd anti-hepatotoxic activity of Swertia sp. have already been estab-
ished in Ayurvedic medical system and validated scientiﬁcally in
nimal system (Mukherjee et al., 1997; Karan et al., 1999; Reen
t al., 2001). Swertia chirayita (Roxb.) Buch.-Ham ex C.B. Clarke,
onsidered to be the most important species of Swertia reported
rom India, for its medicinal properties, has been considered as crit-
cally endangered plant (Pant et al., 2000; Joshi and Dhawan, 2005;
hargava et al., 2009). This plant is substituted by other species
ike S. decussata Nimmo  ex C.B. Clarke and S. bimaculata (Siebold &
ucc.) Hook. f. & Thomson ex C.B. Clarke (Chopra et al., 1956; Phoboo
t al., 2010). Metabolites such as terpenoids, ﬂavonoids, iridoid
lycosides and xanthones are considered as active constituents of
wertia sp., xanthones being the main active secondary metabolite
Brahmachari et al., 2004; Nag et al., 2015).
In a previous study antioxidant, anti-glycosidase and anti-
cetylcholinesterase properties of S. chirayita and the two
ubstitutes were reported from the laboratory (Nag et al., 2015).
lthough the hepatoprotective property of S. chirayita is well
nown, the mode of action for hepatoprotection has not yet been
tudied. The active principles for hepatoprotection are also not
nown. -Glucuronidase inhibitory properties of the extracts of
hese plants would further validate their hepatoprotective prop-
rty. So, the aim of the study was to compare metabolite proﬁle
nd -glucuronidase inhibitory activity of three important species
f Swertia i.e. S. chirayita, S. decussata and S. bimaculata in order to
dentify the active constituents.
aterials and methods
lant material
Leafy shoots of three species of Swertia, Gentianaceae, namely
wertia chirayita (Roxb.) Buch.-Ham ex C.B. Clarke (Voucher no.
ot 332S-1), S. bimaculata (Siebold & Zucc.) Hook. f. & Thomson
x C.B. Clarke (Voucher No. Bot 332S-2) were collected from Dar-
eeling Himalayas. The third species S. decussata Nimmo  ex C.B.
larke (Voucher No. Bot 332S-3) was collected from the Western
hats, India. Voucher specimens are available in the Department
f Botany, University of Calcutta. The two names S. chirayita and
. decussata are unresolved as per IPNI (International Plant Names
ndex).
hemicals and reagents
-Glucuronidase (ex. bovine liver), 4-nitrophenyl--d-
lucuronide; methoxyamine hydrochloride, N-methyl-N-
trimethylsilyl) triﬂuoroacetamide with 1% trimethylchlorosilane
MSTFA), adonitol and FAME (Fatty Acid Methyl Ester) markers
ere obtained from Sigma–Aldrich (St. Louis, MO, USA); HPLC
rade acetonitrile, formic acid, water, methanol, chloroform and
yridine from Merck Specialities Private Limited (Mumbai, India).
ix standard compounds: mangiferin, amarogentin, bellidifolin,
werchirin/methylbellidifolin, decussatin and 1-hydroxy-3, 5,
-trimethoxy xanthone were available in the laboratory.
ample preparation
Methanolic extracts of the leafy shoots of Swertia sp. were pre-
ared by reﬂuxing dried, ground materials with methanol for 5 h.
or each plant material, the ﬁltrate, after extraction, was evapo-
ated to dryness under reduced pressure. Different concentrations
f the methanolic extract and that of reference compounds weremacognosia 27 (2017) 105–111
used for studying the enzyme inhibition activity in vitro as well as
for HPLC and GC/MS analysis.
Assay for ˇ-glucuronidase inhibition
-Glucuronidase inhibition assay was carried out as per the
method of Kim et al. (1999) with modiﬁcation. In brief, 100 l of
-glucuronidase (986.4 units/ml in 0.1 M phosphate buffer, pH 7.0)
and 340 l of test solution/reference standard of various concentra-
tions in 0.1 M phosphate buffer (pH 7.0) were pre-incubated at 37 ◦C
for 15 min. Following the pre-incubation, 60 l of p-nitrophenyl--
d-glucuronide (3.15 mg/ml in 0.1 M phosphate buffer, pH 7.0) was
added and incubated at 37 ◦C for 50 min. The colour developed was
read at 405 nm in spectrophotometer. Controls were devoid of test
samples. The percent inhibition was calculated as follows:
Inhibition (%) =
[
Control OD − Sample OD
Control OD
]
× 100.
HPLC analysis
The HPLC analysis was performed on an Agilent 1260 (Agilent
Technologies, USA) HPLC system consisting of a quaternary pump,
a column temperature controller and a diode-array detector (DAD).
The analytical column (Agilent Eclipse plus C18, 100 × 4.6 mm,
3.5 m)  was used for the analysis. The mobile phase was composed
of solvent A (acetonitrile) and solvent B (0.1%formic acid aqueous,
v/v). The linear gradient programme followed was: 10% A at 0 min,
30% A at 20 min, 60% A at 35 min  and 80% A at 45 min  (Du et al.,
2012). The ﬂow rate was 0.7 ml/min. 20 l aliquots were injected.
UV spectra of the peaks were recorded from 190–400 nm over a
range of 8 different UV wavelengths (210, 214, 230, 250, 254, 260,
273, and 280 nm respectively).
GC/MS analysis
GC–MS analysis was  performed using Agilent 7890 A GC  [soft-
ware driver version 4.01 (054)] equipped with 5795C inert MSD
with Triple Axis Detector. The column used for quantiﬁcation anal-
ysis was HP-5MS capillary column [Agilent J & W;  GC Columns
(USA)] of dimensions 30 m × 0.25 mm × 0.25 m. The method of
Kind et al. (2009) was  followed after modiﬁcation (Das et al.,
2016). The analysis was performed under the following oven tem-
perature programme: oven ramp 60 ◦C (1 min  hold), to 325 ◦C at
10 ◦C/min, held for 10 min  before cool-down producing a run time
of 37.5 min. The injection temperature was  set at 250 ◦C, the MSD
transfer line at 290 ◦C and the ion source at 230 ◦C. Helium was
used as the carrier gas (ﬂow rate 0.723 ml/min; carrier linear veloc-
ity 31.141 cm/s). The dried crude extract was  derivatized using
methoxyamine hydrochloride and MSTFA to increase the volatil-
ity of the metabolites. A mixture of internal Retention Index (RI)
markers (methyl esters of C8, C10, C12, C14, C16, C18, C20, C22,
C24 and C26 linear chain length fatty acids) (2 l) was  added to
each sample. Derivatized samples were injected via split mode
(split ratio 10:1) on to the column. Mass spectra ranging 30–500 m/z
were recorded. Automated mass spectral deconvolution and iden-
tiﬁcation system (AMDIS) was  used to deconvolute and identify
chromatographic peaks. The metabolites were identiﬁed by com-
paring the fragmentation patterns of the mass spectra, retention
times (RT) and retention indices (RI) with entries of mass spec-
tra, RT and RI in Agilent GC-MS Metabolomics RTL Library (2008)
(Agilent Technologies, USA). The relative response ratios of all the
metabolites were calculated after normalizing the peak areas of the
metabolites by extract dry weight and the peak area of the internal
standard.
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tatistical analysis
Each experiment was repeated four–ﬁve times. Percentage
nhibition in activity is presented as mean ± standard deviation.
egression equations were prepared from the concentrations of the
xtracts and percentage inhibition of enzyme activity. IC50 (concen-
ration of sample required to inhibit 50% enzyme activity) values
ere calculated from these regression equations. The differences
n activity were calculated by Tukey’s and Bonferroni’s tests.
esults and discussions
The entire plant of S. chirayita is used in traditional sys-
em of medicine (Joshi and Dhawan, 2005). During the present
tudy leafy shoots could be collected. So methanolic extracts of
he leafy shoots of three species of Swertia were tested for -
lucuronidase inhibitory activity. Concentration required for 50%
nhibition of enzyme activity (IC50 value) for silymarin was  detected
o be 794.62 ± 10.01 g/ml. So, initially, -glucuronidase inhibi-
ion activities of all three species were measured at 500 g/ml. It
as observed that S. bimaculata had lowest activity at the tested
oncentration (Fig. 1). The activities of S. chirayita and S. decus-
ata were higher with no signiﬁcant differences in activity between
hem. So the IC50 values of the two species S. chirayita and S.
ecussata were determined. The extracts inhibited the enzyme in
 dose dependent manner. It was observed that S. chirayita had
ower IC50 value between the two species indicating stronger activ-
ty (Fig. 2). IC50 values of both the extracts were signiﬁcantly
0.00
S. chirayita S. decussata Silymarin
Fig. 2. Comparison of enzyme activity.
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ig. 3. HPLC chromatogram of (A) Swertia chirayita; (B) Swertia decussata; (C) Swertia bimaculata compared with reference compounds as mirrored images. 1: mangiferin; 2:
marogentin; 3, 4: bellidifolin and 1-hydroxy-3,5,8-trimethoxy xanthone; 5: decussatin; 6: swerchirin.
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Table 1
Comparison of HPLC identiﬁed metabolites among three species of Swertia in elution order.
Standard/reference compounds S. chirayita S. decussata S. bimaculata
Relative response ratio per g extract
Mangiferin 1.084 ± 0.39 0.758 ± 0.17 0.209 ± 0.02
Amarogentin 0.376 ± 0.07 – 0.040 ± 0.01
Bellidifolin + 1-Hydroxy-3,5,8-trimethoxy xanthone 0.661 ± 0.22 1.463 ± 0.31 0.043 ± 0.01
Decussatin 0.159 ± 0.02 1.130 ± 0.21 0.066 ± 0.01
Swerchirin 0.233 ± 0.06 0.452 ± 0.17 –
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pounds were compared with that of silymarin. The activities
of the xanthones tested were proportional to their concentra-
tions (Fig. 4). All the xanthones showed inhibitory activities
signiﬁcantly higher than that of the commercial drug (Fig. 5).
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Fig. 4. -Glucuronidase
ower than that of silymarin. The bioactivity of a plant is due
o the phytoconstituents present in it. For a comparative study
f the metabolite proﬁle in the three species, identiﬁcation and
emiquantitative analyses of the metabolites were performed by
PLC with photodiode array detection and GC–MS following a
etabolomics approach. HPLC proﬁle of the three species of Swer-
ia (Fig. 3) showed the conﬁrmed presence of three xanthones
swerchirin, decussatin, mangiferin) and the iridoid amarogentin.
ellidifolin and 1-hydroxy-3,5,8-trimethoxy xanthone could not be
eparated from each other by HPLC as their retention time (RT)
nd absorbance were same. Semiquantitative comparison of the
ormalized peak area revealed that mangiferin was present in max-
mum concentration in S. chirayita, followed by S. decussata and S.
imaculata.  Amarogentin and swerchirin were not detected in S.
ecussata and S. bimaculata respectively. Decussatin was found to
e in maximum amount in S. decussata. A comparative account of
he HPLC identiﬁed metabolites has been represented in Table 1.
C–MS based metabolomics approach helped in identiﬁcation of
2 compounds from the methanol extract of three species of Swer-
ia.  Five amino acids, twenty one organic acids, one inorganic acid,
ight fatty acids, sixteen phenols, eight sugars, seven sugar alcohols,
ve terpenoids and one other organic compound (porphine) were
dentiﬁed. A semi quantitative comparison, based on the relativentration (µg/ml)
ition by the xanthones.
response ratio per g extract, of the identiﬁed metabolites has been
represented in Table 2. S. chirayita presented maximum number of
metabolites followed by S. bimaculata and S. decussata respectively.
Five xanthones and the iridoid amarogentin, isolated from
S. chirayita previously (Nag et al., 2015), were tested for their
-glucuronidase inhibitory property. The activities of the com-Fig. 5. Comparison of -glucuronidase inhibitory activity of Swertia xanthones with
silymarin. 1: Mangiferin; 3: Bellidifolin; 4: 1-Hydroxy-3,5,8-trimethoxy xanthone;
5:  Decussatin; 6: Swerchirin.
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Table  2
Comparative metabolic proﬁle of three species of Swertia using GC/MS.
Metabolites Relative response ratio per g extract
Swertia chirayita Swertia decussata Swertia bimaculata
Amino acids
N-Ethylglycine 1.13 ± 1.09 – –
N-Acetyl-l-glutamic acid 15.73 ± 2.85 – 21.72 ± 9.41
l-Glutamic acid (dehydrated) 14.43 ± 1.50 1.57 ± 0.71b –
l-Pyroglutamic acid – – 17.12 ± 3.46
Allantoin 37.14 ± 8.73 – –
Organic acids
l-(+) Lactic acid 28.97 ± 2.06 25.03 ± 7.83 137.05 ± 14.21a
Glycolic acid 6.83 ± 0.31 2.74 ± 3.95 12.21 ± 0.83a
Oxalic acid 0.98 ± 0.31 – 4.00 ± 2.27a
Malonic acid 3.82 ± 0.91 – 2.88 ± 1.66
Maleic  acid 2.59 ± 0.29 2.21 ± 0.45 1.75 ± 1.00
Succinic  acid 86.36 ± 2.13 1.62 ± 0.08b 98.39 ± 7.51a
Glyceric acid 90.34 ± 2.72 4.77 ± 0.82b 67.42 ± 3.79b
Fumaric acid 103.78 ± 7.32 7.43 ± 1.57b 18.97 ± 3.81b
Citraconic acid 1.03 ± 0.22 – 0.34 ± 0.25b
Citramalic acid 3.79 ± 0.92 – –
Mandelic acid 1.05 ± 0.38 – 0.84 ± 0.19
d-Malic  acid 705.76 ± 25.78 6.08 ± 0.58b 296.55 ± 44.42b
Adipic acid – – 0.76 ± 0.66
Citric  acid 19.33 ± 4.44 – 17.68 ± 11.19
Gluconic acid lactone 144.13 ± 14.48 41.30 ± 5.64b 76.96 ± 8.32b
Gluconic acid 15.29 ± 7.38 – –
2-Isopropylmalic acid 1.51 ± 0.19 – –
3-Hydroxy-3-methylglutaric acid (dicrotalic acid) 3.29 ± 0.13 – –
Ribonic acid-gamma-lactone 22.24 ± 35.46 – –
4-Guanidinobutyric acid 0.93 ± 0.30 – –
Nicotinic acid 2.04 ± 0.87 – 2.74 ± 0.81
Inorganic acid
Phosphoric acid 14.97 ± 2.36 3.99 ± 0.45b 5.66 ± 1.15b
Fatty acids
Lauric acid 1.26 ± 0.13 1.44 ± 0.73 6.16 ± 2.69a
Behenic acid 8.71 ± 1.06 – 14.63 ± 3.04a
Myristic acid – – 6.79 ± 1.82
Palmitic  acid 109.52 ± 11.08 94.42 ± 15.02 247.32 ± 10.48a
Linoleic acid 26.08 ± 5.82 3.69 ± 2.31b 27.39 ± 7.70c
Oleic acid 32.02 ± 9.41 4.93 ± 3.89b 20.48 ± 16.95
Stearic  acid 64.63 ± 7.34 64.87 ± 10.13 116.75 ± 13.21a
Arachidic acid 4.13 ± 0.99 – 20.27 ± 4.24a
Phenols
Benzoic acid – – 1.97 ± 0.22
O-Acetylsalicylic acid – – 3.60 ± 0.35
4-Hydroxybenzoic acid 9.44 ± 0.72 – 4.75 ± 0.12b
2,3-Dihydroxybenzoic acid 41.22 ± 0.14 22.78 ± 1.75b 112.23 ± 2.24a
4-Hydroxy-3-methoxybenzoic acid 56.08 ± 1.65 1.48 ± 0.40b 47.02 ± 0.72b
Gentisic acid – 3.58 ± 1.76 33.83 ± 6.61c
Shikimic acid 1.47 ± 0.21 – –
3,4-Dihydroxybenzoic acid 43.59 ± 16.66 – 8.83 ± 0.67b
Quinic acid 2.06 ± 0.33 5.29 ± 2.96 26.20 ± 0.77a
Coniferyl alcohol 6.90 ± 1.95 – 22.27 ± 9.60a
4-Hydroxycinnamic acid – 11.30 ± 5.60 –
Ferulic acid – 7.76 ± 6.08 –
Sinapyl alcohol – – 3.46 ± 1.96
Caffeic  acid 0.86 ± 0.09 1.44 ± 0.72 –
Neohesperidin 0.95 ± 0.34 –
Isoquercitrin 59.38 ± 8.10 – –
Sugars
Methyl--d-galactopyranoside 105.99 ± 1.29 26.71 ± 14.48b 45.95 ± 40.50b
Sucrose 1482.49 ± 114.56 27.04 ± 4.29b 1682.28 ± 1055.76c
Lactose 46.34 ± 43.84 – –
d-(+)-Trehalose 248.92 ± 66.71 22.69 ± 7.72b 86.93 ± 15.65b
Rafﬁnose 2.46 ± 1.91 – 6.39 ± 5.06
Melezitose 3.70 ± 1.99 3.19 ± 0.28 4.55 ± 3.22
d-(+)-Melezitose 1.98 ± 0.83 86.62 ± 100.91 –
Adenosine 9.66 ± 7.90 – 6.95 ± 1.24
Sugar  alcohols
Glycerol 108.61 ± 1.07 58.94 ± 1.09b 563.47 ± 10.97a
Glycerol 1-phosphate 2.98 ± 0.26 – –
D-Threitol 58.63 ± 4.42 7.61 ± 1.60b 4.60 ± 0.93b
Arabitol 81.81 ± 24.82 47.28 ± 17.36 –
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Table 2 (Continued)
Metabolites Relative response ratio per g extract
Swertia chirayita Swertia decussata Swertia bimaculata
d-Mannitol 533.42 ± 19.80 12.45 ± 1.06b 66.75 ± 1.01b
d-Sorbitol 199.74 ± 2.90 115.11 ± 18.17b 323.37 ± 47.73a
Galactinol 37.99 ± 6.29 – –
Terpenoids
Phytol  – – 3.44 ± 0.66
Loganin – 105.87 ± 12.81c 34.05 ± 7.11
Palatinitol 28.05 ± 15.45 – 8.68 ± 4.87
Stigmasterol 39.26 ± 5.79 3.15 ± 2.76b 42.25 ± 7.60
Lanosterol – – 35.94 ± 7.56
Macrocycle organic compound
Porphine 6.41 ± 4.38 – –
–, not detected.
a Signiﬁcantly higher than S. chirayita.
b Signiﬁcantly lower than S. chirayita.
c Signiﬁcantly higher between S. decussata and S. bimaculata.
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sig. 6. Comparison of -glucuronidase inhibitory activity of organic and phenolic
cids with respect to silymarin.
angiferin showed the best -glucuronidase inhibition with an
C50 value of 16.06 ± 0.05 g/ml or 0.038 mM followed by swer-
hirin (IC50 162.84 ± 3.72 g/ml or 0.565 mM),  decussatin (IC50
95.11 ± 5.03 g/ml or 0.646 mM),  1-hydroxy-3,5,8-trimethoxy
anthone (IC50 245.97 ± 4.19 g/ml or 0.814 mM)  and bellidifolin
IC50 390.26 ± 2.92 g/ml or 1.424 mM).  However, the bitter iridoid
ompound, amarogentin did not show any enzyme inhibitory activ-
ty. Out of 72 metabolites identiﬁed by GC–MS, nine compounds,
vailable in the laboratory, were tested for their -glucuronidase
nhibitory activity. These were succinic acid, d-malic acid, cit-
ic acid, O-acetylsalicylic acid, 4-hydroxybenzoic acid, quinic acid,
-hydroxycinnamic acid, sucrose and glycerol. 4-Hydroxybenzoic
cid, 4-hydroxycinnamic acid, sucrose and glycerol did not have any
-glucuronidase inhibitory activity. Remaining ﬁve compounds
nhibited -glucuronidase in a dose-dependent manner. Compari-
on of their activities with respect to silymarin had been illustrated
n Fig. 6. Among these, citric acid (IC50 1.77 ± 0.02 mg/ml) and
uinic acid (IC50 2.91 ± 0.02 mg/ml) showed activity close to sily-
arin (IC50 0.79 ± 0.01 mg/ml).
Xanthones had already been reported to possess a range of
harmacological actions (Peres et al., 2000). S. chirayita, S. decus-
ata and S. bimaculata are considered to be a natural source
f tetraoxygenated xanthones (Peres et al., 2000). Mangiferin, a
anthone-C-glycoside, had previously been reported to possess
ntioxidant (Nag et al., 2015); anti-diabetic and antitumour activ-
ties to name a few (Suryawanshi et al., 2006). Bellidifolin and
werchirin had been found to be potent hypoglycemic agent (Bajpaiet al., 1991; Basnet et al., 1995). In addition, swerchirin, had also
been reported to be hepatoprotective (Hajimehdipoor et al., 2006)
on paracetamol-induced hepatotoxicity in mice models. Several
studies that had been carried out to advocate the hepatoprotective
and anti-hepatotoxic property of this genus credits this attribute
to the xanthone content present in extract of the plant. The ﬁve
xanthones that had been considered in our study showed good -
glucuronidase inhibition in comparison to the commercial drug,
silymarin, thereby proposing a possible mechanism of hepatopro-
tective action via -glucuronidase inhibition. These ﬁndings had
not been reported earlier in literature. The present study also
reveals that some organic acids viz., succinic acid, d-malic acid, citric
acid and phenolic compounds viz., O-acetylsalicylic acid and quinic
acid have -glucuronidase inhibitory properties. Citric acid was
reported earlier to reduce lipopolysaccharide induced liver injury
and oxidative stress (Abdel-Salam et al., 2014). So, -glucuronidase
inhibition property of the constituents present in Swertia sp. may  be
a mechanism for hepatoprotective activity of these plants. Further
in vivo study is required in this regard.
Conclusion
The properties of three Swertia sp. e.g.  S. chirayita, S. decus-
sata and S. bimaculata to inhibit -glucuronidase, a mechanism for
hepatoprotection, were assessed and the contributory constituents
had been identiﬁed. Several xanthones were identiﬁed to be major
components to have signiﬁcantly higher -glucuronidase inhibi-
tion properties than that of silymarin. Metabolites other than the
xanthones, probably also contribute to the bioactivity of different
Swertia species by synergistic effect. The present ﬁndings suggest
that -glucuronidase inhibition may  be one of the mechanisms for
the hepatoprotective property of Swertia sp. Further in vivo study
is required to support the claim.
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